STAB

Statera Biopharma, Inc. Common Stock

Delisted

STAB was delisted on the 11th of January, 2023.

17 hedge funds and large institutions have $1.07M invested in Statera Biopharma, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

Holders
17
Holders Change
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Renaissance Technologies
1
Renaissance Technologies
New York
$702K 273,251 -16,100 -6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$135K 52,592
Barclays
3
Barclays
United Kingdom
$114K 44,450 +44,450 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$45K 17,598
BRWA
5
B. Riley Wealth Advisors
Florida
$44K 17,013
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$22K 8,620 +5,000 +138%
Carson Wealth (CWM LLC)
7
Carson Wealth (CWM LLC)
Nebraska
$2K 438
BlackRock
8
BlackRock
New York
$2K 741
Osaic Holdings
9
Osaic Holdings
Arizona
$1K 290
Wells Fargo
10
Wells Fargo
California
$1K 457 +425 +1,328%
AIC
11
Archer Investment Corporation
Indiana
$771 300 +300 New
FDCDDQ
12
Federation des caisses Desjardins du Quebec
Quebec, Canada
$257 100
WS
13
Wedbush Securities
California
-13,321 Closed
Citadel Advisors
14
Citadel Advisors
Florida
-12,009 Closed
Victory Capital Management
15
Victory Capital Management
Texas
-1,410 Closed
IA
16
IFP Advisors
Florida
$0 150
VFA
17
Valeo Financial Advisors
Indiana
CFGS
18
Concourse Financial Group Securities
Alabama
Morgan Stanley
19
Morgan Stanley
New York
$0 100
Bank of Montreal
20
Bank of Montreal
Ontario, Canada
$0 31
Bank of America
21
Bank of America
North Carolina
$0 111 +11 +11%
TRCT
22
Tower Research Capital (TRC)
New York
$0 142 +142 New